A pilot study to evaluate the effect of TWO kinds of MEditation programs on Hwa-byung patients
- Conditions
- Hwa-byung (anger syndrome)Mental and Behavioural DisordersDepression
- Registration Number
- ISRCTN75740459
- Lead Sponsor
- Korea Health Industry Development Institute (Korea, South)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
1. Male or female from 20 to 65 years old
2. Diagnosed as hwa-byung using hwa-byung SCID (Structured Clinical Interview for DSM-?W)
3. Written informed consent form taken
4. Has no problems with communication (reading, writing, listening, speaking etc)
1. Has a severe neuro or psychiatric disorder
2. Has a history of major neuro-psychiatric disorder (autism, learning disorder, mental retardation etc.)
3. If the patient was in need of regular medication or psychotherapy, had a change in medication or dose of anti-depressant, barbiturate, hormone therapy in the past month
4. Seriously irritable patient
5. Participated in any other clinical trial within last one month from the screening day
6. Had a regular mind-body relaxation training more than one month within last year including any kind of meditation, qigong, etc.
7. Cannot understand written informed consent form or follow this study because of mental retardation, mental or emotional problems
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hwa-byung symptoms scale at baseline (before the treatment) and post treatment (after eight sessions of treatment).
- Secondary Outcome Measures
Name Time Method 1. State-Trait Anger Expression Inventory (STAXI) (only 20 items in state anger and trait anger)<br>2. Hospital Anxiety and Depression Scale of Korea (HAD)<br>3. Korean version of Mindfulness Attention Awareness Scale (K-MAAS)<br>4. Korean version of Difficulties in Emotion Regulation Scale (K-DERS)<br>5. Self-Compassion Scale (SCS)<br>6. Acceptance and Action Questionnaire (AAQ)<br><br>Measured at baseline (before the treatment) and post treatment (after eight sessions of treatment).